×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Alpha-1 Antitrypsin Deficiency Market 2032: Epidemiology Analysis, Therapeutic Advancements, Regulatory ...
openPR.com
Press release - ABNewswire - Alpha-1 Antitrypsin Deficiency Market 2032: Epidemiology Analysis, Therapeutic Advancements,...
1 day ago
Perspective Therapeutics (NYSEAMERICAN:CATX) Coverage Initiated by Analysts at Royal Bank of Canada
Defense World
Read Perspective Therapeutics (NYSEAMERICAN:CATX) Coverage Initiated by Analysts at Royal Bank of Canada at Defense World.
6 days ago
Heron Therapeutics: Zynrelef Eases Shareholder Pain (HRTX)
Seeking Alpha
HRTX has received approval for its supplemental New Drug Application for Zynrelef, allowing its use in more surgical procedures.
1 month ago
NorthStar Medical Radioisotopes Announces Supply Agreement with Nucleus RadioPharma for Alpha-emitting ...
Imaging Technology News
July 5, 2023 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of...
10 months ago
Perspective Therapeutics (NYSEAMERICAN:CATX) Earns Overweight Rating from Analysts at Cantor Fitzgerald
Defense World
Read Perspective Therapeutics (NYSEAMERICAN:CATX) Earns Overweight Rating from Analysts at Cantor Fitzgerald at Defense World.
1 week ago
Voyager Therapeutics: A Shot At Making Gene Therapy Deliver Easier (NASDAQ:VYGR)
Seeking Alpha
Voyager Therapeutics investors need to be patient as the biotech targets hard to treat Alzheimer's and Parkinson's. Read why the best days...
2 months ago
Perspective Therapeutics (NYSEAMERICAN:CATX) Stock Rating Reaffirmed by Oppenheimer
MarketBeat
Oppenheimer restated an "outperform" rating and set a $1.50 price target (up from $1.20) on shares of Perspective Therapeutics in a research...
1 month ago
Tools for Developing Actinium-225 Therapeutics | Discover Los Alamos National Laboratory
Los Alamos National Lab (.gov)
The concept of using radioactive isotopes for medical applications has become commonplace in the last several decades.
3 months ago
TerraPower Isotopes
TerraPower
TerraPower's assessment shows that select isotopic materials may be effectively used in Targeted Alpha Therapy for cancer patients.
17 months ago
Transcend Therapeutics, a mental health-focused biotechnology company, announces Series A funding round of $40 ...
PR Newswire
PRNewswire/ -- Transcend Therapeutics, a biotechnology company that develops medicines to treat neuropsychiatric diseases,...
14 months ago